García L, de Miguel R, Ramos J A, Fernàndez-Ruiz J J
Instituto Complutense de Drogodependencias, Department of Biochemistry, Complutense University, Madrid, Spain.
Drug Alcohol Depend. 1996 Nov;42(3):155-66. doi: 10.1016/s0376-8716(96)01276-8.
The present study has been designed to explore further the existence of a persistent, but 'silent' alteration in the adult functionality of midbrain dopaminergic neurons following perinatal cannabinoid exposure. To this end, we evaluated the responsiveness of these neurons, measured at the neurochemical or behavioral levels, to pharmacological challenges with a variety of dopaminergic drugs administered to adult male and female rats that had been exposed to delta 9-tetrahydrocannabinol (THC) or vehicle during the perinatal period. Results were as follows: In the first experiment, we tested the magnitude of motor inhibition caused by administration of dopaminergic receptor antagonists. The most interesting observation was that the administration of SCH 23390, a D1 antagonist, produced a more marked motor inhibition, reflected by a greater decrease in the ambulation measured in an open-field test, in adult animals of both sexes when they had been exposed perinatally to THC. This did not occur with the motor inhibition caused by sulpiride, a D2 antagonist. In the second experiment, we evaluated the sensitivity of midbrain dopaminergic neurons to amphetamine (AMPH), which causes, through different mechanisms, a decrease in dopamine (DA) metabolism. The most interesting observation was that adult females, when exposed perinatally to THC, exhibited a trend to lesser response to AMPH, in terms of decreasing DA metabolism, than oil-exposed females. This was observed in dopaminergic terminals reaching the limbic forebrain area, but not in those terminals reaching the striatum, and was a specific effect for THC-exposed adult females because it was not observed in THC-exposed adult males. In the third experiment, we evaluated the in vivo synthesis of DA in midbrain dopaminergic neurons by analyzing the magnitude of L-3,4-dihydroxyphenylalanine (L-DOPA) accumulation caused by the blockade of L-DOPA decarboxylase with NSD 1015. The most worthy finding was that, as occurred in the above experiment, adult females, when exposed perinatally to THC, tended to exhibit a higher ability to synthesize DA in vivo in the limbic forebrain but not in the striatum, as reflected by the increased L-DOPA accumulation observed after NSD 1015 administration. As in the above experiment, this was not seen in males. In summary, our results are consistent with the possible existence of subtle and sexually dimorphic changes in the sensitivity of midbrain dopaminergic neurons in adulthood caused by the exposure to THC during perinatal development. These silent changes could be revealed after the administration of drugs which specifically act on key processes of dopaminergic neurotransmission, such as the synthesis, reuptake and catabolism of DA and its binding to receptors.
本研究旨在进一步探索围产期暴露于大麻素后,中脑多巴胺能神经元的成年功能是否存在持续但“沉默”的改变。为此,我们评估了这些神经元在神经化学或行为水平上对多种多巴胺能药物药理学挑战的反应性,这些药物被施用于围产期暴露于δ9-四氢大麻酚(THC)或赋形剂的成年雄性和雌性大鼠。结果如下:在第一个实验中,我们测试了多巴胺能受体拮抗剂给药引起的运动抑制程度。最有趣的观察结果是,D1拮抗剂SCH 23390的给药在围产期暴露于THC的成年两性动物中产生了更明显的运动抑制,这在旷场试验中测量的移动减少中得到了更明显的体现。而D2拮抗剂舒必利引起的运动抑制则未出现这种情况。在第二个实验中,我们评估了中脑多巴胺能神经元对苯丙胺(AMPH)的敏感性,苯丙胺通过不同机制导致多巴胺(DA)代谢减少。最有趣的观察结果是,围产期暴露于THC的成年雌性在DA代谢减少方面对AMPH的反应趋势比暴露于油的雌性小。这在到达边缘前脑区域的多巴胺能终末中观察到,但在到达纹状体的终末中未观察到,并且这是围产期暴露于THC的成年雌性的特异性效应,因为在围产期暴露于THC的成年雄性中未观察到。在第三个实验中,我们通过分析用NSD 1015阻断L-多巴脱羧酶引起的L-3,4-二羟基苯丙氨酸(L-DOPA)积累的程度,评估了中脑多巴胺能神经元中DA的体内合成。最有价值的发现是,与上述实验一样,围产期暴露于THC的成年雌性在边缘前脑而不是纹状体中倾向于表现出更高的体内合成DA的能力,这通过NSD 1015给药后观察到的L-DOPA积累增加得以体现。与上述实验一样,在雄性中未观察到这种情况。总之,我们的结果与围产期发育期间暴露于THC导致成年期的中脑多巴胺能神经元敏感性可能存在细微的性别差异变化一致。这些沉默的变化可以在施用特异性作用于多巴胺能神经传递关键过程(如DA的合成、再摄取和分解代谢及其与受体的结合)的药物后显现出来。